BioMarin Pharmaceutical Inc.
(NASDAQ:BMRN)|
14.66 +0.06 (0.41%) Dec 02 - Close |
|
|
|
After-Hours 19.00 +4.34 (29.60%) Tue, 2 Dec 2008 7:40 PM
- Compare BMRN with:
- View: Line | Candlestick
Company Profile
BioMarin Pharmaceutical Inc.
105 Digital Drive
Novato, CA 94949
United States - Map
Phone: (415) 506-6700
Fax: (415) 382-7889
Website: www.biomarinpharm.com
State of incorporation: Delaware
CEO: Jean-Jacques Bienaime
Employees: 525
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
A developer of carbohydrate-enzyme therapies
The Company develops and commercializes biopharmaceuticals for serious diseases and medical conditions.
Recent news for BMRN
-
Motley Fool - Nov 28 at 12:58 ET
-
BioMarin to Present at the Piper Jaffray Healthcare Conference
PR Newswire - Nov 25 at 9:00 ET
-
EDGAR Online - Nov 24 at 12:43 ET
-
New Emerging Biotech and Pharma Company Index
Seeking Alpha - Nov 23 at 10:14 ET
-
BioMarin shares rise on Citi upgrade to 'Buy'
AP - Nov 21 at 7:46 ET
-
BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
PR Newswire - Nov 21 at 4:30 ET
-
Movers roundup: JPMorgan Chase, Foot Locker
AP - Nov 21 at 2:36 ET
-
BioMarin shares rise on Citi upgrade to 'Buy'
AP - Nov 21 at 12:26 ET
-
Analysts' Upgrades, Downgrades: Microsoft
TheStreet.com - Nov 21 at 8:49 ET
-
Biomarin Pharm upgraded by Citigroup
Briefing.com - Nov 21 at 5:28 ET
Top members owning BMRN
-
Top 54%
-35.57%3m:
-36.47%YTD:
-
Top 20%
-8.30%3m:
-8.30%YTD:
-
Top 32%
-20.64%3m:
-18.55%YTD: